Having lower blood sugar can make you feel tired, especially as your body adjusts
2 3 Interestingly, in patients with type-2 diabetes, some studies showed GLP-1 analogs to lower glucose levels and HbA1c without affecting the patients insulin or C-peptide levels
Notably, trials involving type 2 diabetes populations exhibited a higher odds ratio for NAION compared to obesity trials, reinforcing existing literature indicating that metabolic syndrome and type 2 diabetes may be significant risk factors for NAION, the authors noted
10 mg, 12.5 mg, and 15mg doses are considered maintenance doses
In the 68-week trials 7,9 , reductions in weight, waist circumference, blood pressure and HbA 1c appeared to plateau around week 60 with semaglutide
In a sub-analysis in people with albuminuria at baseline, lixisenatide reduced UACR by 21% (in people with microalbuminuria) 39% (in people with macroalbuminuria)